Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Director effectiveness assessment

13 Feb 2020 07:00

RNS Number : 8370C
Barclays PLC
13 February 2020
 

 

13 February 2020

Barclays PLCBarclays Bank PLC

Director effectiveness assessment: disclosure of regulatory investigation

In accordance with the UK Corporate Governance Code, all of the current Directors of Barclays PLC will be submitting themselves for election or re-election at the Annual General Meeting to be held on 7 May 2020, and will be unanimously recommended by the Board for election or re-election as appropriate. Further information in this regard will be set out in the Notice of Meeting which will be published in due course.

In deciding whether to recommend Jes Staley for re-election, the Board has carried out its usual formal and rigorous performance assessment, which it does in respect of the effectiveness of each of the Directors. As part of its determination in respect of Mr. Staley, the Board has had regard to media reports in the past 6 months that have highlighted historical links between Mr. Staley and Jeffrey Epstein.

As has been widely reported, earlier in his career Mr. Staley developed a professional relationship with Mr. Epstein. In the summer of 2019, in light of the renewed media interest in the relationship, Mr. Staley volunteered and gave to certain executives, and the Chairman, an explanation of his relationship with Mr. Epstein. Mr. Staley also confirmed to the Board that he has had no contact whatsoever with Mr. Epstein at any time since taking up his role as Barclays Group CEO in December 2015.

The relationship between Mr. Staley and Mr. Epstein was the subject of an enquiry from the Financial Conduct Authority ("FCA"), to which the Company responded. The FCA and the Prudential Regulation Authority subsequently commenced an investigation, which is ongoing, into Mr. Staley's characterisation to the Company of his relationship with Mr. Epstein and the subsequent description of that relationship in the Company's response to the FCA.

Based on a review, conducted with the support of external counsel, of the information available to us and representations made by Mr. Staley, the Board (the Executive Directors having been recused) believes that Mr. Staley has been sufficiently transparent with the Company as regards the nature and extent of his relationship with Mr. Epstein. Accordingly, Mr. Staley retains the full confidence of the Board, and is being unanimously recommended for re-election at the Annual General Meeting.

The Board will continue to cooperate fully with the regulatory investigation, and will provide a further update as and when it is appropriate to do so.

- ENDS -

For further information, please contact:

Investor Relations

Media Relations

Adam Strachan

Tom Hoskin

+1 212 526 8442

+44 (0) 20 7116 4755

James Johnson 

+44 (0)20 7116 7233

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group.

For further information about Barclays, please visit our website home.barclays 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLLLFBLLBBBB
Date   Source Headline
31st May 20173:43 pmRNSPublication of Final Terms
30th May 20174:18 pmRNSPublication of Final Terms
22nd May 20172:30 pmRNSPublication of Final Terms
17th May 20174:16 pmRNSPublication of Final Terms
16th May 20172:39 pmRNSPublication of Supplement to GSSP BPs
16th May 20172:36 pmRNSPublication of Supplement to Registration Document
16th May 201710:46 amRNSPublication of Final Terms
12th May 20177:05 amRNSPre-Stabilisation Period Announcement
11th May 201711:30 amRNSPublication of Suppl.Prospcts
11th May 20178:17 amRNSPre-Stabilisation Notice
10th May 20179:15 amRNSPre-Stabilisation Notice - CaixaBank
8th May 20173:20 pmRNSPublication of Final Terms
5th May 201710:00 amRNSPublication of Suppl.Prospcts
2nd May 20174:36 pmRNSPublication of Final Terms
2nd May 201711:42 amRNSPost-Stabilisation Notice - Coventry B/S
2nd May 20177:04 amRNSStabilisation Notice
28th Apr 20177:00 amRNS1st Quarter Results
26th Apr 20175:32 pmRNSPublication of Final Terms
26th Apr 20178:23 amRNSCoventry Pre Stabilisation Notice
26th Apr 20177:00 amRNSResults of Placing of Ibstock plc Shares
25th Apr 20174:40 pmRNSProposed Placing of Ibstock plc Shares
12th Apr 20179:27 amRNSPost Stabilisation Notice - Caixa Geral
12th Apr 20179:22 amRNSPost-Stabilisation Notice - Bupa Finance
10th Apr 20174:29 pmRNSPublication of Final Terms
10th Apr 20177:00 amRNSStatement re FCA and PRA investigations
30th Mar 20179:15 amRNSPre-Stabilisation Notice - BUPA
29th Mar 20177:00 amRNSResults of Placing of JRP Group PLC Shares
28th Mar 20174:36 pmRNSProposed Placing of JRP Group PLC Shares
23rd Mar 20179:09 amRNSPre-Stabilisation Notice - Caixa Geral
17th Mar 201712:08 pmRNSPublication of Suppl.Prospcts
13th Mar 201711:00 amRNSPublication of Final Terms
10th Mar 20172:30 pmRNSPublication of a Prospectus
10th Mar 20178:58 amRNSPublication of Final Terms
10th Mar 20177:00 amRNSResults of Placing of Ibstock plc Shares
9th Mar 20174:37 pmRNSProposed Placing of Ibstock plc Shares
8th Mar 201712:01 pmRNSPublication of Supplementary.Prospectus
3rd Mar 201710:42 amRNSPublication of Final Terms
28th Feb 20174:15 pmRNSPublication of Base Prospectus
27th Feb 201710:00 amRNSDirectorate Change
24th Feb 201711:00 amRNSAnnual Report on Form 20-F
24th Feb 20179:00 amRNSNotice of redemption of Notes
23rd Feb 20173:30 pmRNSAnnual Financial Report
23rd Feb 20172:00 pmRNSFinal Results
23rd Feb 20177:00 amRNSFinal Results
9th Feb 201712:28 pmRNSPublication of Final Terms
2nd Feb 20173:28 pmRNSPost-Stabilisation Notice - Wells Fargo
27th Jan 20177:00 amRNSResults of Placing in Countryside Properties PLC
26th Jan 20174:53 pmRNSPlacing of Shares in Countryside Properties PLC
20th Jan 20178:59 amRNSPre-Stabilisation Notice - Wells Fargo
13th Jan 20174:05 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.